Your browser doesn't support javascript.
loading
Advances in the treatment of macular edema secondary to retinal vein occlusion / 中华实验眼科杂志
Chinese Journal of Experimental Ophthalmology ; (12): 65-69, 2018.
Article in Chinese | WPRIM | ID: wpr-699691
ABSTRACT
Retinal vein occlusion (RVO) is a common blinding retinal vascular disease,and the most important complication of vision loss is macular edema (ME).The main treatment for ME secondary to RVO was laser photocoagulation therapy previously,but some researches showed that the laser therapy did not see an obvious curative effection,and might cause certain danger in some patients.In recent years,with the further understanding and research of the pathogenesis of RVO,intravitreal injection or posterior subtenon injection of triamcinolone acetonide and antivascular endothelial growth factor drugs like ranibizumab,bevacizumab,aflibercept,conbercept intravitreal injections,as well as vitreous retinal surgery gradually became the main research directions of ME secondary to RVO.The following to be a review for the advances in the treatment of macular edema secondary to RVO.

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Chinese Journal of Experimental Ophthalmology Year: 2018 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Chinese Journal of Experimental Ophthalmology Year: 2018 Type: Article